Countable Labs and Promega Partner for Sample Preparation and Rare Variant Detection
The agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.
Read MorePosted by CLP Edit Staff | Jun 26, 2026 | Amplification Technologies, Company News |
The agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.
Read MorePosted by CLP Edit Staff | Jun 25, 2026 | Dementias & Alzheimer’s |
The study highlights the role of brain-derived nanoparticles in identifying the disease through minimally invasive testing.
Read MorePosted by CLP Edit Staff | Jun 24, 2026 | Cancer, Company News |
The approval allows Quest Diagnostics to offer its minimal residual disease test for patients in all 50 states.
Read MorePosted by CLP Edit Staff | Jun 23, 2026 | Cancer, Molecular Diagnostics |
The whole-genome sequencing assay is now available for breast, colorectal, and renal cancers following new clinical study results.
Read MorePosted by CLP Edit Staff | Jun 22, 2026 | Colorectal |
The test detect signs of colorectal cancer and precancerous growths using a home collection kit.
Read More